ASIA News
It can diagnose diabetic retinopathy and diabetic macular oedema in 5-10 seconds.
It plans to launch 100 more e-clinics in the next 12 months.
The company is seeking new partnerships to expand its virtual home care programme.
HIMSS22 APAC
The Digital Innovation Showcase saw five startups pitching their solutions to a panel of judges and healthcare industry professionals from the APAC region.
Also, Syntekabio has launched its cloud service platform for AI drug discovery.
They can access Intellect's self-guided CBT programmes and one-on-one coaching until April next year.
Partner hospitals will be provided with telemedicine support and resources to mobilise critical stroke patients.
Also, Royal Philips has expanded the roll-out of its AR surgical navigation solution to Japan.
Also, Max Life in India has developed an analytics solution that detects inaccurate medical reports in real time.
It is part of an artificial pancreas system that mimics the human body's closed-loop system for insulin production.